Lipocine
LPCN
LPCN
47 hedge funds and large institutions have $36.5M invested in Lipocine in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
47
Holding in Top 10
1
Calls
$88K
Puts
$144K
Top Buyers
| 1 | +$2.12M | |
| 2 | +$935K | |
| 3 | +$364K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$317K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$175K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$1.22M | |
| 3 | -$790K | |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$401K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$194K |